article Open AccessTop 1% cited
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
Clinical Infectious Diseases · 2011 · Vol. 52(3) · pp. e18–e55
Catherine Liu✉(University of California, San Francisco)Arnold S. Bayer(University of California, Los Angeles)Sara E. Cosgrove(Johns Hopkins University)Robert S. Daum(University of Chicago)Scott K. Fridkin(Centers for Disease Control and Prevention)Rachel Gorwitz(Centers for Disease Control and Prevention)Sheldon L. Kaplan(Baylor College of Medicine)Adolf W. Karchmer(Harvard University)Donald P. Levine(Wayne State University)Barbara E. Murray(Texas Center for Infectious Disease)Michael J. Rybak(Wayne State University)David A. Talan(University of California, Los Angeles)Henry F. Chambers(University of California, San Francisco)
Abstract
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
Antimicrobial Resistance in StaphylococcusInfective Endocarditis Diagnosis and ManagementStreptococcal Infections and TreatmentsMedicineBacteremiaVancomycinStaphylococcus aureusIntensive care medicineMethicillin-resistant Staphylococcus aureusPneumoniaEndocarditisInfectious disease (medical specialty)Antibiotics
MeSH terms
AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolHumansInfantInfant, NewbornMiddle AgedStaphylococcal InfectionsUnited StatesVancomycinMethicillin-Resistant Staphylococcus aureus
Funding
- Pfizer
- Sanofi
- Infectious Diseases Society of America
- Astellas Pharma
- Centers for Disease Control and Prevention
- Sanofi Pasteur
Citations
4,125
FWCI
157.35
field-weighted impact
References
381
Percentile
100%
vs. same field & year
Citations per year
Cited by
The study of subcutaneous pressure in cellulitis of the leg and its relationship to management
International Journal of Surgery Science · 2019 · 0 citations
Detection of MRSA and MSSA biofilms in clinical specimens from a tertiary care hospital located in Hyderabad
International Journal of Advanced Research in Medicine · 2024 · 0 citations
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
Clinical Microbiology Reviews · 2015 · 4,961 citations
Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per Liter
Antimicrobial Agents and Chemotherapy · 2012 · 618 citations
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Circulation · 2020 · 3,552 citations
Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment
Critical Care · 2017 · 589 citations
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
Clinical Infectious Diseases · 2012 · 2,197 citations
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Journal of Thoracic and Cardiovascular Surgery · 2014 · 985 citations
References
Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia
Journal of Clinical Microbiology · 2004 · 835 citations
Increased US Emergency Department Visits for Skin and Soft Tissue Infections, and Changes in Antibiotic Choices, During the Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus
Annals of Emergency Medicine · 2008 · 446 citations
Staphylococcus aureus Bacteremia
Medicine · 2003 · 523 citations
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
Intensive Care Medicine · 2007 · 4,939 citations
Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections
Clinical Infectious Diseases · 2005 · 1,591 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.